Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
GermanyStudy on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy of Emrusolmin for Treating Adults with Multiple System Atrophy
GermanyStudy on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal
GermanyStudy of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)
GermanyStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
GermanyStudy of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
GermanyLong-term safety study of garadacimab (CSL312) for prevention of hereditary angioedema attacks
GermanyStudy on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery
GermanyStudy on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GermanyStudy of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis
GermanyStudy of Trastuzumab Deruxtecan with or without Pertuzumab for Patients with HER2-positive Metastatic Breast Cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
